Mark S. Wilke, PhD

Bio

Dr. Mark Wilke is a partner based out of Vancouver, Canada, practising in the firm's global Intellectual Property and Life Sciences groups.

Mark received the Best Lawyers 2025 Intellectual Property Law "Lawyer of the Year" in Canada award. His practice focuses on international patent prosecution and strategic patent portfolio counseling across a broad range of industries, including pharmaceuticals, biotechnology, agriculture, and cleantech, with an emphasis on patenting innovative technologies in the areas of molecular biology, immunology, biochemistry, chemistry, chemical engineering, and medical devices.

Prior to his legal career, Mark completed a doctorate at the University of British Columbia, where he investigated the regulation of antibiotic resistance in pathogenic superbugs using X-ray crystallography and nuclear magnetic resonance.

Mark is a registered patent agent in both Canada and the United States.

Scam Warning
Have you received an email bearing my name, but originating from an email address other than @gowlingwlg.com? Does it suggest urgent action needs to be taken to preserve your trademark rights?

It is not from me and not legitimate.

Read more in this advisory from the College of Patent and Trademark Agents.

Qualifications

Carrière

2013

Patent Agent, Canada

2013

Patent Agent, USA

2013

Trademark Agent, Canada

Formation

2011

University of British Columbia, JD

2008

University of British Columbia, PhD, Biochemistry

2002

University of Guelph, B.Sc., Biochemistry

Langues parlées

Anglais

Memberships

Canadian Bar Association
Intellectual Property Institute of Canada (IPIC)

Publications et conférences

Wilke, MS et al., "Patenting across three jurisdictions", Intellectual Property Magazine, April 2020, pages 37-38.

Wilke MS, Prohibiting Medical Method Patents: A Criticism of the Status Quo, 2011, C.J.L.T. 9(2), 2009.

Wilke MS, Heller M, Creagh L, Haynes C, McIntosh L, Poole K, Strynadka NC (2008) The crystal structure of MexR from Pseudomonas aeruginosa in complex with its anti-repressor ArmR. Proc Natl Acad Sci USA 105, 14832-37.

Daigle DM, Cao L, Fraud S, Wilke MS, Pacey A, Klinoski R, Strynadka NC, Dean CR, and Poole K. (2007) A Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa. J Bacteriol 189, 5441-51.

Wilke MS, Lovering AL, Strynadka NC (2005) Beta-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 8, 525-33.

Wilke MS, Hills TL, Zhang HZ, Chambers HF, Strynadka NC (2004) Crystal structures of the apo and penicillin-acylated forms of the BlaR1 beta-lactam sensor of Staphylococcus aureus. J Biol Chem 279, 47278-87.

Bateman KP, Baker J, Wilke M, Lee J, Leriche T, Seto C, Day S, et al. (2004) Detection of covalent adducts to cytochrome P450 3A4 using liquid chromatography mass spectrometry. Chem Res Toxicol 17, 1356-61.

Mark S. Wilke, PhD

Partner

Bio

Bio

Qualifications

Qualifications

Carrière

Formation

Langues parlées

Memberships

Publications et conférences

Publications et conférences

Gardez le contact

Mark S. Wilke, PhD

Partner

Bio

Bio

Qualifications

Qualifications

Carrière

Formation

Langues parlées

Memberships

Publications et conférences

Publications et conférences

Recevez nos mises à jour

Gardez le contact